In this study, three polymorphisms in the VEGF gene (−1154 G/A, −460 T/C, and +405 G/C) were assessed in relation to the risk of BCC incidence in a population from northern Poland and some clinical aspects of the malignancy. The gene discussed is VEGFA; the disease is skin basal cell carcinoma.